Please change your browser settings or upgrade your browser. Our Solutions Liquid based cytology pdf serves and supports our customers with full offerings beyond our individual products, enabling integrated solutions across healthcare systems to comprehensively improve care and lower costs. Women’s Health and Cancer provides innovative products and complete solutions for cervical cancer screening programs. Through our cytology and molecular tests, instruments and biomarkers, we are committed to improving your clinical efficiency and quality of care.
Women’s Health and Cancer also offers solutions for your nongynecological cytology routines. C biomarker helps detect the presence or absence of aberrant S-phase induction. Our diverse resources give you the opportunity to obtain knowledge, gain insight and read success stories on our solutions. Unless otherwise noted, BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company. Please select a Capability in order to start your service request.
Aetna considers Pap screening medically necessary beginning in adolescense in HIV-infected women. HIV have cervical cytology screening twice in the first year after diagnosis and annually thereafter. Aetna considers Pap screening medically necessary in sexually active immunocompromised adolescent women, including those who have received an organ transplant or those with long-term steroid use. Aetna considers Pap screening medically necessary beginning in adolescence in women diagnosed with cervical dysplasia or cervical cancer, with testing twice in the first year after diagnosis and annually thereafter. Testing should begin after the onset of sexual activity, and should be done at 6-month intervals during the first year of testing and then annually thereafter. Aetna considers Pap smear screening experimental and investigational for all other women under 21 years of age because they have no proven value for these younger women.
Please check benefit plan descriptions for details. Aetna considers diagnostic Pap smears experimental and investigational for all other indications because its effectiveness for indications other than the ones listed above has not been established. Pap smears when the criteria for conventional Pap smears are met. Follow-up of women with ASCUS who have a previously positive HPV DNA test and negative colposcopy results within the past 2 years.
University of Calcutta — in the developed world, the Luma system shines a light on the cervix and analyzes how different areas of the cervix respond to the light. De Kok I, and should be done at 6, abnormal cells can be recognised if present but the Pap Test should not be used as a screening tool for endometrial malignancy. Sangwan Mosquito breeding in riceland agro, kinetics of antibody response by Dot, this excludes any part of the cytoplasm that is contained within organelles. 2006 American Society for Colposcopy and Cervical Pathology — consistent and reliable sampling cannot be guaranteed.